Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions

Sleep

Volumn 35, Issue 10, 2012, Pages 1359-1366

  Dauvilliers, Yves ^a,b,c   Delalleé, Nathalie ^d   Jaussent, Isabelle ^b,c   Scholz, Sabine ^a   Bayard, Sophie ^a,b,c   Croyal, Mickael ^d   Schwartz, Jean Charles ^d   Robert, Philippe ^d  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d Bioprojet Biotech ^*  (France)

Author keywords

Cerebrospinal fluid; Histamine; Hypersomnia; Hypocretin; Narcolepsy; Tele methylhistamine

Indexed keywords

ANTICATAPLECTIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL STIMULANT AGENT; HISTAMINE; OREXIN A; TELE METHYLHISTAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CATAPLEXY; CEREBROSPINAL FLUID LEVEL; CHILD; CONTROLLED STUDY; DAYTIME SOMNOLENCE; ELECTROSPRAY MASS SPECTROMETRY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPERSOMNIA; IDIOPATHIC DISEASE; IDIOPATHIC HYPERSOMNIA; LABORATORY DEVICE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NORMAL VALUE; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RADIOIMMUNOASSAY; REM SLEEP; SCHOOL CHILD; SLEEP; TANDEM MASS SPECTROMETRY;

ADULT; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HISTAMINE; HUMANS; MALE; METHYLHISTAMINES; MIDDLE AGED; NARCOLEPSY; POLYSOMNOGRAPHY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84867045078     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2114     Document Type: Article

References (26)

1. Schwartz JC. Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol 1977;17:325-39.
2. Haas H, Sergeeva O, Selbach O. Histamine in the nervous system. Physiol Rev 2008;88:1183-241.
3. Watanabe T, Taguchi Y, Shiosaka S, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984;295:13-25 (Pubitemid 14155851)
4. Faucard R, Schwartz JC. Neuropharmacology of histamine in brain. In: Sibley DR, Hanin I, Kuhar M, Skolnick P (eds). Handbook of contemporary neuropharmacology. New York: John Wiley & Sons, 2007: 299-364.
5. Nishino S, Sakurai E, Nevsimalova S, et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls, Sleep 2009;32:175-80.
6. Kanbayashi T, Kodama T, Kondo H, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009;32:181-7.
7. Bassetti CL, Baumann CR, Dauvilliers Y, Croyal M, Robert P, Schwartz JC. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res 2010;19:620-3
8. Croyal M, Dauvilliers Y, Labeeuw O, Capet M, Schwartz JC, Robert P. Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization. Anal Biochem 2011;409:28-36.
9. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 2nd ed: Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
10. Dauvilliers Y, Montplaisir J, Molinari N, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001;57:2029-33. (Pubitemid 33126870)
11. Iber C, Ancoli-Israel S, Chesson A, Quan S. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
12. Dauvilliers Y, Abril B, Charif M, et al. Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level. Neurology 2007;69:1300-1. (Pubitemid 47429033)
13. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias, Arch Neurol 2002;59:1553-62.
14. Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74:1667-73 (Pubitemid 37542057)
15. Scammell TE, Mochizuki T. Is low histamine a fundamental cause of sleepiness in narcolepsy and idiopathic hypersomnia? Sleep 2009;32:133-4.
16. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. (Pubitemid 46209316)
17. Goldschmidt RC, Hough LB, Glick SD. Rat brain mast cells: contribution to brain histamine levels. J Neurochem 1985;44:1943-7. (Pubitemid 15047283)
18. Kiviranta T, Tuomisto L, Airaksinen EM. Histamine in cerebrospinal fluid of children with febrile convulsions. Epilepsia 1995;36:276-80.
19. Borg J, Warter JM, Schlienger JL, et al. Neurotransmitter modifications in human cerebrospinal fluid and serum during hepatic encephalopathy. J Neurol Sci 1982;57:343-56. (Pubitemid 13212270)
20. Khandelwal JK, Hough LB, Morrishow AM, Green JP. Measurement of tele-methylhistamine and histamine in human cerebrospinal fluid, urine, and plasma. Agents Actions 1982;12:583-90. (Pubitemid 13115788)
21. Prell GD, Green JP, Kaufmann CA, et al. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 1995;14:93-104.
22. Swahn C, Sedvall G. Identification and determination of tele-methylhistamine in cerebrospinal fluid by gas chromatography-mass spectrometry. J Neurochem 1981;37:461-6. (Pubitemid 11059464)
23. Baumann C, Khatami R, Werth E. Bassetti CL. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry 2006;77:402-4.
24. Zeitzer JM, Kodama T, Buckmaster CL, et al. Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey. J Sleep Res 2012:21:189-94.
25. Lin JS, Dauvilliers Y, Arnulf I, et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/-mice and patients, Neurobiol Dis 2008;30:74-83.
26. Schwartz JC, The histamine H3 receptor: from discovery to clinical trials with Pitolisant. Brit J Pharmacol 2011;163:713-21